Powerful Drug to Advance in the Fight Against Familial Amyloidosis (IMAGE)
Caption
Three-dimensional structure of the TTR mutation that causes familial amyloid cardiomyopathy bound to two tolcapone molecules that stabilise it and prevent it from aggregating.
Credit
UAB
Usage Restrictions
None
License
Licensed content